SCHEMBL304910

SCHEMBL304910

OC1C[CH]CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6444426 1.00
SCHEMBL6442934 1.00
SCHEMBL8924581 0.95 TSHR (0.38)
SCHEMBL1144484 0.92
SCHEMBL3597864 0.89 TSHR (0.45)
SCHEMBL2538037 0.89
SCHEMBL3027119 0.89 TSHR (0.45)
SCHEMBL4948795 0.87 TSHR (0.43)
SCHEMBL18169824 0.84
SCHEMBL7012417 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1004 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118019736-A Molecular gel compound designed based on cereblon protein and application thereof 标新生物医药科技(上海)有限公司 2024-05-10 CN claimed
CN-117983302-A Catalyst containing ferrocene PNP ligand for ethylene selective tetramerization and preparation method and application thereof 华东理工大学 2024-05-07 CN claimed
CN-117886798-A Substituted benzimidazoles and use thereof 河南中医药大学 2024-04-16 CN claimed
WO-2024051766-A1 MOLECULAR GLUE COMPOUND BASED ON CEREBLON PROTEIN DESIGN AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-03-14 WO claimed
US-20230416205-A1 COMPOUNDS, COMPOSITIONS, AND METHODS TENVIE THERAPEUTICS, INC. 2023-12-28 US claimed
EP-4247376-A1 COMPOUNDS, COMPOSITIONS, AND METHODS Denali Therapeutics Inc. (US) 2023-09-27 EP claimed
CN-116507608-A Compounds, compositions, and methods 戴纳立制药公司 2023-07-28 CN claimed
CN-116284536-A Copolymer and binder for lithium battery 上海华谊三爱富新材料有限公司 2023-06-23 CN claimed
CN-111606883-B Sulfur-containing compound based on glutarimide skeleton and application thereof 上海科技大学 2023-05-09 CN claimed
US-20230089351-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2023-03-23 US claimed
US-5972559-A A PHOTORESIST MIXTURE COMPRISING AN ORGANIC SOLVENT, A COPOLYCARBONS BASE RESIN, A PHOTOACID GENERATOR, AND AN AROMATIC ALKYLENE CARBOXYLIC ACID COMPOUND; FOR IMPROVING THE FOOTING ON NITRIDE FILM SUBSTRATES AND POST EXPOSURE DELAY SHIN-ETSU CHEMICAL CO., LTD. (JP) 1999-10-26 US claimed
US-5876900-A POLYHYDROXYSTYRENE POLYMER SHIN-ETSU CHEMICAL CO., LTD. (JP) 1999-03-02 US claimed
EP-0322242-B1 Adenosine derivatives GLAXO GROUP LTD (GB) 1998-04-01 EP claimed
WO-1996029331-A1 IMIDAZOQUINAZOLINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION DR. KARL THOMAE GMBH (DE) 1996-09-26 WO claimed
EP-0167265-B1 Method of repelling insects COULSTON INT CORP (US) 1995-12-20 EP claimed
CN-1109749-A Methods for inhibiting uterine fibrosis LILLY CO ELI (US) 1995-10-11 CN claimed
CN-1105853-A Methods for inhibiting bone loss LILLY CO ELI (US) 1995-08-02 CN claimed
CN-1105362-A Methods for lowering serum cholesterol LILLY CO ELI (US) 1995-07-19 CN claimed
US-5032583-A Cardiovascular disorders GLAXO GROUP LIMITED (GB) 1991-07-16 US claimed
EP-0322242-A2 Adenosine derivatives GLAXO GROUP LIMITED (GB) 1989-06-28 EP claimed